Abstract

espanolEn 2018 se iniciaron en Espana 12.245 procesos de baja por cancer de mama, 9.336 alcanzaron los 365 dias de duracion, se considero incapacidad permanente en 2.201 trabajadoras. El 76% de las bajas iniciales por cancer de mama alcanzan o sobrepasan los 365 dias de duracion, y de estas bajas de tan larga duracion el 18% pasaran a incapacidad permanente. El cancer de mama en la mujer en “edad laboral” tiene un pronostico de supervivencia del 86%, pero tan solo el 53% retorna al trabajo de forma efectiva, frente al 47% que no permanecera trabajando, bien por declaracion de incapacidad permanente, bien por desistimiento no pudiendo rendir en el trabajo, o bien por despido en relacion a la perdida de capacidades, cuando no, por haber pasado a desempleo durante la baja. Material y metodo: Revision bibliografica en Pubmed, Medline y Scielo hasta mayo de 2019. Estudio de procesos de incapacidad temporal por cancer de mama en 2018; analisis de 408 procesos de cancer de mama de duracion de incapacidad de mas de 365 dias, con alta medica laboral y valoracion de secuelas; comparacion con estudio previo de la IT en 2015. Conclusiones: El cancer de mama presenta alto riesgo de exclusion social y laboral, se hace necesario medidas para facilitar el retorno laboral efectivo, reconociendo la “aptitud sobrevenida” de la superviviente al cancer de mama, que retorna al trabajo. Por ello hay que posibilitar la reintegracion laboral progresiva, abordar los factores psicosociales, evitar la controversia entre el alta medica para trabajar y la no aptitud para el trabajo, incentivar a las empresas para la adopcion de medidas organizacionales de reinsercion, realizacion del Mapa de Incapacidad para conocer el impacto incapacitante laboral, valorar la incapacidad como indicador de retorno al trabajo, e indicador de salud publica laboral. EnglishFrom the 12,245 breast cancer withdrawal processes which began in Spain during 2018, 9,336 reached 365 days long and 2,201 workers were considered permanently disabled to work. 76% of the initial casualties for breast cancer had reached or exceed 365 days and of these long-term sick leave 18% would have become permanently disabled. Breast cancer in women of „working age“ has a survival prognosis rate of 86%, but only 53% return to work effectively compared to 47% who will not continue working. This may be either due to a declaration of permanent disability, or due to withdrawal as not being able to give up on the job, or because of dismissal in relation to the loss of abilities, if not for having gone into unemployment during the sick leave. Material and Method: Bibliographic review in Pubmed, Medline and Scielo until May 2019. Study of processes of temporary disability due to breast cancer in 2018; analysis of 408 breast cancer processes of disability duration of more than 365 days, with occupational medical discharge and sequel assessment; comparison with the previous study of Temporary Disability in 2015. Conclusions: Breast cancer presents a high risk of social and occupational exclusion. Measures are needed to ease the effective return of work, recognizing the “survived aptitude” of the breast cancer survivor, who is returning to work. Addressing psychosocial factors, avoiding controversy between medical discharge to work and non-work skills, encouraging companies to adopt organizational reintegration measures, carrying out the Disability Map to know the disabling work impact and assessing the disability as an indicator of return to work and public health at work is therefore necessary for achieving a progressive return to work.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call